Picture of Ahn-Gook Pharmaceutical Co logo

001540 Ahn-Gook Pharmaceutical Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Ahn-Gook Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,142-1,3883,7446,879998
Depreciation
Amortisation
Non-Cash Items3,5646,9214,1709,12610,016
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital12,518974-10,949-19,147-17,365
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities22,07811,1901,4721,788-1,328
Capital Expenditures-3,738-24,119-4,035-2,931-5,474
Purchase of Fixed Assets
Other Investing Cash Flow Items-23,85614,6937,1549,36222,660
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-27,594-9,4263,1186,43117,186
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6,655-11,460-3,846-3,728-5,093
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,274-9,9788814,56910,772